Price
$165.68+15.99%Social Signal Score
Company Profile
- Sector
- Financial Services
- Industry
- Asset Management
- Beta
- 0.53
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
XLVhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70+40.00%Social Signal Score
Mentions (30)
- News (RSS)livemint·12d ago·Positive
US ETFs to Buy for Samvat 2083: Samco recommends 2 ETFs with potential upside of up to 60% for Indian investors Samco Wealth recommends US-listed energy ETF XLE and healthcare ETF XLV as long-term hedges against oil-price volatility and rupee depreciation. It sees potential upside of 47% and 60%, respectively, and suggests holding both for at least two years.
View source ↗ - Newscnbc.com·15d ago·Negative
Why the prognosis for healthcare stocks is uncertain ahead of Congress' new makeup Healthcare stocks may struggle to find momentum as the Democrats get ready to take over Congress.
View source ↗ - News (RSS)economictimes·15d ago·Neutral
…d US-listed exchange-traded funds (ETFs).The brokerage has identified two ETFs: the Energy Select Sector SPDR Fund (XLE) and the Health Care Select Sector SPDR Fund (XLV).The XLE ETF provides exposure to the US energy sector and is positioned as a potential hedge against rising crude oil prices. This is particularly relevant for Indian investors because higher oil prices can hurt domestic equities through their impact on import costs, inflation and the rupee.The XLV ETF, which tracks the US heal…
View source ↗ - 4chan /biz/biz·17d ago·Neutral
WHATS THE PLAY? XLE/crude? TLT puts? Defensives too expensive, semis/AI falling knife, hyper scalers too dependent on OAI/ANT There is nothing to buy except energy if you think the Iran war restarts. XLF, XLP, XLV all had blowoff tops yesterday
View source ↗ - 4chan /biz/biz·17d ago·Neutral
>>62861545 XLV
View source ↗ - News (RSS)fool·27d ago·Positive
Which Healthcare ETF Is the Better Buy: Fidelity’s FHLC or State Street’s XLV? XLV concentrates on 61 large-cap S&P 500 names, while FHLC casts a wider net with 365 holdings across mid and small caps. Both charge 0.08% annually.
View source ↗ - News (RSS)zerohedge·32d ago·Neutral
…ductor weighting, fell in sympathy. Foreign markets, including the tech-heavy Korea's KOSPI and Japan's Nikkei, were also down sharply. As we show below, healthcare (XLV), consumer staples (XLP) and other beaten-up value sectors have rallied since October 1, while technology (XLK) moved in the opposite direction. This rotation was primarily a flight to quality within the equity market, but El-Erian thinks it may have also sparked some bond buying. Additionally, El-Erian notes there are "emerging…
View source ↗ - 4chan /biz/biz·34d ago·Neutral
I closed my XLE and XLV positions after making 4% in a few days and dumped it in SCHD. I'd rather just trust the methodology of the dow jones divvie 100 index.
View source ↗ - Newsseekingalpha.com·34d ago·Negative
XLV: Safe Haven, But That Cuts Both Ways XLV (Health Care Select Sector SPDR ETF) broke to new all-time highs, outperforming as a safe haven amid tech sector volatility and AI selloff. Despite tepid Q3 earnings growth, XLV benefits from forward PE compression, weight loss drug advances, AI-driven efficiencies, and improving regulatory clarity. XLV offers insulation from AI-specific risks, rising yields, and macro headwinds, with steady cash flows and manageable debt supporting its defensive appe…
View source ↗ - 4chan /biz/biz·39d ago·Neutral
My real world positions like SCHD XLE and XLV are softening the blow to my overall portfolio.
View source ↗ - 4chan /biz/biz·39d ago·Neutral
look at XLV go!
View source ↗ - 4chan /biz/biz·39d ago·Positive
>>62780798 SCHD and XLV chads are winning bigly. Healthcare can charge as much as they want and generate infinite money to take care of boomers.
View source ↗ - 4chan /biz/biz·44d ago·Neutral
>>62768737 >BUYAN real world babe ETFs like SCHD and XLV >SELLAN some SGOV to fund my purchases >HODLAN VOO GDX and babe ETFs >PLAYAN My Summer Car >WATCHAN cop slop >LISTENAN mike jones >READAN i can't read >EATAN beef and rice >DRINKAN coffee oj and water >FAPPAN tryin not to tbdesu >FEELAN pretty good. glad its the weekend.
View source ↗ - 4chan /biz/biz·44d ago·Neutral
>SCHD XLE XLV i just put 10k into each of these. this is a babe etf market now.
View source ↗ - News (RSS)fool·59d ago·Neutral
XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.
View source ↗ - News (RSS)fool·60d ago·Positive
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks XLV's broader diversification and lower fees appeal to cost-conscious investors, while PJP's concentrated pharma bet has outperformed over the past year.
View source ↗ - Newsfool.com·60d ago·Negative
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks The State Street Health Care Select Sector SPDR ETF (XLV) offers significantly lower ownership costs, with an expense ratio of 0.08% compared to 0.58% for the Invesco Pharmaceuticals ETF (PJP). PJP provides concentrated exposure to 28 pharmaceutical stocks, while XLV holds 61 diversified healthcare companies.
View source ↗ - News (RSS)yahoo·70d ago·Neutral
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors
View source ↗ - News (RSS)fool·70d ago·Neutral
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors XLV's 0.08% expense ratio and 22.7% 1-year return outpace IXJ's global reach, but international diversification comes at a cost.
View source ↗ - Newsfool.com·70d ago·Negative
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors XLV has a significantly lower expense ratio of 0.08% compared to IXJ's 0.38%. IXJ provides broader exposure with 110 holdings across global markets, while XLV concentrates on 60 domestic S&P 500 stocks.
View source ↗ - Newsetftrends.com·72d ago·Negative
Blend Innovative Growth & Defense With Healthcare ETFs All too often, when investors look at the healthcare sector, they mostly see its value for its defensive merits. However, that view may be shortsighted and miss the broader picture in today's market.
View source ↗ - Newsfool.com·76d ago·Positive
If the Fed Hikes Interest Rates This Month, History Says This Is the Smartest ETF to Buy Right Now The State Street Health Care Select Sector SPDR ETF could be a rising rates winner. It easily outpaced the broader market when the Fed hiked rates in 2022.
View source ↗ - 4chan /biz/biz·79d ago·Neutral
thinking about just parking all my money in healthcare stocks like XLV. apparently they go up 100% of time during midterms
View source ↗ - Newsfxempire.com·80d ago·Positive
XLV, XLK and MOO Forecast: Agriculture ETF Breaks Out MOO has recently broken out and is showing real momentum, while XLV continues its uptrend and XLK holds around the 50-day EMA. The agriculture ETF carries the strongest bullish outlook of the three.
View source ↗ - Newszacks.com·88d ago·Neutral
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed exchange traded fund launched on December 16, 1998.
View source ↗ - Newsseekingalpha.com·90d ago·Positive
Healthcare Is Rising: XLV Is A Better Option For Investors Than BME BlackRock Health Sciences Trust (BME) has recently outperformed due to a narrowing NAV discount, not superior portfolio management. XLV, the passive healthcare ETF, has consistently delivered higher total returns and better NAV preservation than BME over 5- and 10-year periods. BME's recent strategy shift away from call options to capital gains distributions has not produced positive alpha relative to XLV.
View source ↗ - Newszacks.com·95d ago·Positive
Healthcare ETFs Are Looking Up: Here's Why Healthcare ETFs are hitting 52-week highs as earnings improve, dealmaking accelerates, FDA approvals stay strong and investors seek defensive growth.
View source ↗ - PodcastCompound And Friends·100d ago·Neutral
… get a drug approved or not approved, it could mean 30% market cap. - Yeah, instantly. - I think that's also why sector investing needs to evolve. You can't just buy XLV or XOI, because industrial is a super diverse, right? You might transport you buying power generation. - So it's already-- - Or airplanes or Uber. - So you're seeing more, not necessarily niche, but sub-sector ETFs launch. - The Madex. - It's the Madex. And that's the kind of-- - The sector is a very artificial. They come from t…
View source ↗ - Newsfool.com·106d ago·Neutral
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026? Vanguard Health Care ETF offers much broader diversification with 411 holdings compared to the 60 stocks in State Street Health Care Select Sector SPDR ETF. State Street Health Care Select Sector SPDR ETF is slightly more cost-effective with an expense ratio of 0.08% versus 0.09% for the Vanguard fund.
View source ↗ - 4chan /biz/biz·112d ago·Neutral
>>62549875 XLV
View source ↗
Congress trades
- Thomas Hawley Tubervillesenate · AL · disclosed Aug 5, 2026 (231d later)Buy$15,001 - $50,000
- Thomas Hawley Tubervillesenate · AL · disclosed Jan 15, 2026 (29d later)Buy$15,001 - $50,000
- Chuck Fleischmannhouse · TN03 · disclosed Feb 13, 2023 (21d later)Sell$1,001 - $15,000
- Kurt Schraderhouse · OR05 · disclosed May 17, 2022 (39d later)Buy$1,001 - $15,000
- Chuck Fleischmannhouse · TN03 · disclosed Feb 11, 2022 (18d later)Buy$1,001 - $15,000
- Kurt Schraderhouse · OR05 · disclosed Dec 23, 2020 (30d later)Sell$1,001 - $15,000
- Patrick Joseph Toomeysenate · PA · disclosed Dec 20, 2017 (1055d later)Buy$1,001 - $15,000
- Patrick Joseph Toomeysenate · PA · disclosed Mar 23, 2015 (52d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
